Symbicort and Common peroneal nerve dysfunction - a phase IV clinical study of FDA data

Summary:

Common peroneal nerve dysfunction is reported as a side effect among people who take Symbicort (budesonide; formoterol fumarate dihydrate), especially for people who are female, 60+ old, also take Singulair, and have Multiple sclerosis.

The phase IV clinical study analyzes which people have Common peroneal nerve dysfunction when taking Symbicort. It is created by eHealthMe based on reports of 112,650 people who have side effects when taking Symbicort from the FDA, and is updated regularly.

What is Symbicort?

Symbicort has active ingredients of budesonide; formoterol fumarate dihydrate. It is often used in asthma. eHealthMe is studying from 114,789 Symbicort users. Check the latest studies of Symbicort.

What is Common peroneal nerve dysfunction?

Common peroneal nerve dysfunction (dysfunction of nerve controlling movement and sensation to the lower leg, foot and toes) is found to be associated with 658 drugs and 1,126 conditions by eHealthMe. Check the latest studies of Common peroneal nerve dysfunction.



On Apr, 21, 2026

112,650 people reported to have side effects when taking Symbicort.
Among them, 36 people (0.03%) have Common peroneal nerve dysfunction.

Could Symbicort cause Common peroneal nerve dysfunction?

Among these 36 people:

What is the gender of people who have Common peroneal nerve dysfunction when taking Symbicort? *

  • female: 84.38 %
  • male: 15.62 %

What is the age of people who have Common peroneal nerve dysfunction when taking Symbicort? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 3.85 %
  • 20-29: 3.85 %
  • 30-39: 19.23 %
  • 40-49: 7.69 %
  • 50-59: 19.23 %
  • 60+: 46.15 %

What are other drugs people take besides Symbicort? *

  1. Singulair: 12 people, 33.33%
  2. Nexium: 7 people, 19.44%
  3. Vitamin D: 6 people, 16.67%
  4. Lasix: 6 people, 16.67%
  5. Wellbutrin: 6 people, 16.67%
  6. Orencia: 6 people, 16.67%
  7. Norvasc: 6 people, 16.67%
  8. Ampyra: 5 people, 13.89%
  9. Celebrex: 5 people, 13.89%
  10. Cymbalta: 5 people, 13.89%

What are other side effects people have besides Common peroneal nerve dysfunction? *

  1. Weakness: 23 people, 63.89%
  2. Fatigue (feeling of tiredness): 19 people, 52.78%
  3. Nausea (feeling of having an urge to vomit): 18 people, 50.00%
  4. Dizziness: 18 people, 50.00%
  5. Gait Disturbance: 16 people, 44.44%
  6. Headache (pain in head): 15 people, 41.67%
  7. Fall: 12 people, 33.33%
  8. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 12 people, 33.33%
  9. Feeling Abnormal: 12 people, 33.33%
  10. Hypoaesthesia (reduced sense of touch or sensation): 11 people, 30.56%

What are the existing conditions these people have? *

  1. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 11 people, 30.56%
  2. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 6 people, 16.67%
  3. Pain: 6 people, 16.67%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 13.89%
  5. Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 5 people, 13.89%
  6. Depression: 5 people, 13.89%
  7. Headache (pain in head): 4 people, 11.11%
  8. Hypersensitivity: 4 people, 11.11%
  9. Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 4 people, 11.11%
  10. Dyspnea (difficult or laboured breathing): 4 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Symbicort and have Common peroneal nerve dysfunction?

- Check whether Common peroneal nerve dysfunction is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Symbicort:

Common peroneal nerve dysfunction treatments and more:

How severe was Common peroneal nerve dysfunction and when was it recovered:

Expand to all the drugs that have ingredients of budesonide; formoterol fumarate dihydrate:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Symbicort:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Common peroneal nerve dysfunction:

Browse all the conditions that are associated with Common peroneal nerve dysfunction:


How the study uses the data?

The study uses data from the FDA. It is based on budesonide; formoterol fumarate dihydrate (the active ingredients of Symbicort) and Symbicort (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: